Floatz logo

Tauroursodeoxycholic

Cholestasis

Beijing Trendful Kangjian Medical Information Consulting Limited CompanyUNKNOWNPhase 3Dormant
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
49/ 100
Competitive Position
89/ 100

Competitive context

8 Active assets in the Cholestasis cohort.

Asset / SponsorPhaseRating
Linerixibat
GlaxoSmithKline
Phase 3BB
Ursodeoxycholic Acid
Assistance Publique - Hôpitaux de Paris
Phase 3BB
Maralixibat
Mirum Pharmaceuticals, Inc.
Phase 3BB
Gabapentin
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Phase 3B
2-(P-(2-(P-CHLOROBENZAMIDO)ETHYL)PHENOXY)-2-METHYLPROPIONIC ACID
Assistance Publique - Hôpitaux de Paris
Phase 3B

View all 24 →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →